Senior Director / Director, Global Medical Affairs (Evidence Generation)
$200k - $325k
- Location
- Cambridge, MA
- Workplace
- Hybrid
- Employment
- Full-time
About this role
Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.
As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
Summary of Position:
The Senior Director / Director, Global Medical Affairs (Evidence Generation), reporting to the VP, Global Medical Affairs, will lead the development and execution of the global evidence generation strategy to support market access, reimbursement, value demonstration, and scientific communication for commercial and pipeline products within the Scholar Rock portfolio.
This individual will serve as the global subject matter expert for evidence generation, responsible for identifying evidence gaps, establishing integrated evidence generation plans, and ensuring the successful execution and dissemination of evidence that demonstrates the clinical, economic, and patient-centered value of Scholar Rock therapies. The role requires strong strategic leadership and cross-functional collaboration with Medical Affairs, Clinical Development, Market Access, Commercial, HEOR, and regional teams to optimize product differentiation and support access for patients worldwide.
The successful candidate will partner closely with global and regional stakeholders to generate evidence that informs healthcare decision-making among healthcare professionals, payers, health technology assessment (HTA) bodies, health systems, advocacy organizations, and other key stakeholders.
\nPosition Responsibilities- Strategic Leadership: Lead the development and execution of global evidence generation strategies that support product value demonstration, reimbursement, market access, and lifecycle management.
- Study Design & Oversight: Direct the design, implementation, and operational oversight of medical affairs-led evidence generation initiatives, ensuring all protocols are executed in strict compliance with global regulatory, ethical, and corporate quality standards. Core modalities include:
- Prospective and retrospective observational studies
- Real-world evidence (RWE) studies and database analyses
- Patient-reported outcome (PRO) research
- Qualitative and quantitative primary research
- Phase IV studies and post-hoc analyses
- Cross-Functional Collaboration: Partner strategically with cross-functional teams to integrate evidence generation strategies into commercial evaluations and portfolio management decisions, successfully demonstrating product value to achieve global market access.
- External Stakeholder Engagement: Establish and maintain robust relationships with external experts, including key opinion leaders (KOLs), clinical researchers, and healthcare decision-makers, to accurately inform evidence needs and study designs.
- Scientific Dissemination: Partner with Medical Communications to develop publication and dissemination strategies that maximize the impact, scientific rigor, and visibility of evidence generation findings.
- Team Development: Support the development and training of global and regional Medical Affairs teams on evidence generation strategies, methodologies, and key study results.
- Project & Resource Management: Efficiently manage multiple evidence generation projects, key performance indicators (KPIs), and associated resources simultaneously, including budgets, CROs/vendors, and external collaborations.
- Culture Driver: Foster a culture of scientific rigor, innovation, compliance, collaboration, and patient focus across all evidence generation activities.
- Education: MD, PhD, or PharmD or equivalent advanced degree in a relevant life sciences discipline.
- Experience & Track Record:
- Director level: Minimum 3–5 years of experience in Evidence Generation, Real-World Evidence, Outcomes Research, or related functions within the pharmaceutical, biotechnology, or life science industry.
- Senior Director level: Minimum 6–8+ years of experience in the tracking, design, and executive delivery of complex global evidence generation strategies within the biopharmaceutical industry.
- Documented track record of delivering measurable project results and cross-functional success.
- Core Competencies: Strong written and verbal communication skills, exceptional interpersonal capabilities, and proven experience managing external vendor relationships.
- Therapeutic Area: Prior experience in neuromuscular diseases and/or rare diseases is highly preferred but not required.
- Travel: Ability to travel domestically and internationally (~15%).
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Apply to Scholar Rock
Clera fills in Scholar Rock's application for you.
How it works
Open the role in Clera
Sign in, and this role opens on your Clera job board, ready to apply.
Clera fills in the application
Clera fills the form from your profile and resume, and asks what's missing.
Track it in Clera
Each application you send shows up in your Clera tracker, sorted by stage.
Ask your AI about this role
It knows you. Clera gives it the role.
First time? Connect Clera once, about a minute.
https://mcp.getclera.comSign in with your Clera account. MCP docs
About Scholar Rock
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock on X.
For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/
For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy/
- Team size
- 51-200 employees people
- Founded
- 2012
- Industry
- Biotechnology
- Workplace
- Hybrid
- Locations
- Cambridge, Massachusetts, United States